Several countries have suspended the use of AstraZeneca’s coronavirus vaccine after a number of recipients suffered blood clots in the days and weeks that followed.
But how prevalent have these incidents been – and should Britons who are about to get the jab to be concerned?
A review from Norway’s medicines agency showed four new cases of “serious blood clotting in adults”.
Meanwhile, the European Medicines Agency (EMA) confirmed that one person in Austria was admitted to a hospital with pulmonary embolism, where there is a blockage in the arteries of the lungs. They died 10 days after they were vaccinated.
Another death involving a blood clot was reported in Denmark.